Abstract

We have identified mutations in Raf-1 that increase binding to Ras. The mutations were identified making use of three mutant forms of Ras that have reduced Raf-1 binding (Winkler, D. G., Johnson, J. C., Cooper, J. A., and Vojtek, A. B. (1997) J. Biol. Chem. 272, 24402-24409). One mutation in Raf-1, N64L, suppresses the Ras mutant R41Q but not other Ras mutants, suggesting that this mutation structurally complements the Ras R41Q mutation. Missense substitutions of residues 143 and 144 in the Raf-1 cysteine-rich domain were isolated multiple times. These Raf-1 mutants, R143Q, R143W, and K144E, were general suppressors of three different Ras mutants and had increased interaction with non-mutant Ras. Each was slightly activated relative to wild-type Raf-1 in a transformation assay. In addition, two mutants, R143W and K144E, were active when tested for induction of germinal vesicle breakdown in Xenopus oocytes. Interestingly, all three cysteine-rich domain mutations reduced the ability of the Raf-1 N-terminal regulatory region to inhibit Xenopus oocyte germinal vesicle breakdown induced by the C-terminal catalytic region of Raf-1. We propose that a direct or indirect regulatory interaction between the N- and C-terminal regions of Raf-1 is reduced by the R143W, R143Q, and K144E mutations, thereby increasing access to the Ras-binding regions of Raf-1 and increasing Raf-1 activity.

Highlights

  • The importance of the Raf protein kinases for cell growth and differentiation has been demonstrated in animals, tissue culture cells, Drosophila, and Caenorhabditis elegans

  • Mutations that disrupt the structure of the cysteine-rich domain (CRD) reduce binding to Ras in vitro, suggesting that the Ras-binding domain (RBD) and the CRD may both contribute to Raf-1 binding [25]

  • In one case we found a single mutation in the RBD (N64L) that directly interacts with the residue that was mutated in the Ras mutant it complements, suggesting structural complementarity

Read more

Summary

THE JOURNAL OF BIOLOGICAL CHEMISTRY

21578 –21584, 1998 Printed in U.S.A. Identification of Residues in the Cysteine-rich Domain of Raf-1 That Control Ras Binding and Raf-1 Activity*. Ras interacts with the C-terminal part of the CR1 region of Raf, the cysteine-rich domain (CRD) [24, 25]. In all other cases the mutated residue was either Arg-143 or Lys-144 in the CRD These mutants have generally increased interaction with mutant and non-mutant Ras and are somewhat activated in vivo. These mutations decrease the ability of the isolated N-terminal regulatory region to inhibit the isolated C-terminal kinase domain. We propose that these mutations decrease an inhibitory interaction between the N-terminal regulatory region and the C-terminal kinase domain and expose the Raf-1 N terminus for Ras binding

EXPERIMENTAL PROCEDURES
Ras mutant designation
RESULTS
Ras mutant used in selection
DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.